Financials

News Discussions Technicals Seasonals

002932 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Wuhan Easy Diagnosis Biomedicine Co., Ltd. is engaged in the research, development, production and sales of POCT rapid diagnostic reagents and rapid detection instruments. Its products include Blood Gas Analysis, ImmunoDiagnosis, Molecular Diagnosis and Coagulation Analysis. The company was founded on January 28, 2008 and is headquartered in Wuhan, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

002932 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company